User contributions
- 02:56, 12 October 2023 (diff | hist) . . (+108) . . Part:BBa K4587194 (current)
- 02:43, 12 October 2023 (diff | hist) . . (-162) . . Part:BBa K4587194 (→Profile)
- 02:40, 12 October 2023 (diff | hist) . . (+162) . . Part:BBa K4587194
- 02:33, 12 October 2023 (diff | hist) . . (+12) . . Part:BBa K4587194
- 20:22, 11 October 2023 (diff | hist) . . (+7,833) . . Part:BBa K4587194
- 16:12, 13 October 2022 (diff | hist) . . (+2,790) . . Part:BBa K4161900:Experience (→Applications of BBa_K4161900)
- 16:12, 13 October 2022 (diff | hist) . . (+2,789) . . Part:BBa K4161900
- 15:58, 13 October 2022 (diff | hist) . . (+1,448) . . Part:BBa K4161900:Design (One of the most important proteins in type III secretion system (T3SS) of pathogenic Shigella called ipaD is our attack target8. Because ipaD is the primary trigger to form translocon pores within the host cell membrane, the inhibition of it would probabl)
- 15:43, 13 October 2022 (diff | hist) . . (+440) . . Part:BBa K4161500:Design (→References) (current)
- 15:55, 12 October 2022 (diff | hist) . . (+1,502) . . Part:BBa K4161301 (current)
- 15:54, 12 October 2022 (diff | hist) . . (+1,339) . . Part:BBa K4161301
- 15:51, 12 October 2022 (diff | hist) . . (+1,339) . . Part:BBa K4161301:Experience (→Applications of BBa_K4161301) (current)
- 15:50, 12 October 2022 (diff | hist) . . (+1,448) . . Part:BBa K4161301:Design (One of the most important proteins in type III secretion system (T3SS) of pathogenic Shigella called ipaD is our attack target8. Because ipaD is the primary trigger to form translocon pores within the host cell membrane, the inhibition of it would probabl) (current)
- 15:49, 12 October 2022 (diff | hist) . . (+1,339) . . Part:BBa K4161301:Experience